Cwm LLC Boosts Holdings in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Cwm LLC significantly increased its stake in DENTSPLY SIRONA Inc. by 139.9%, acquiring 133,010 additional shares in the second quarter, now holding approximately 0.11% of the company.
• Several research analysts have recently issued mixed ratings on DENTSPLY SIRONA, with upgrades from hold to buy, while price targets have been adjusted down by firms like Wells Fargo and Evercore ISI.
• DENTSPLY SIRONA reported a quarterly EPS of $0.52, exceeding expectations, but its quarterly revenue has declined 4.9% year-over-year, now forecasting an EPS guidance of 1.800-2.000 for FY 2025.

Cwm LLC raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 139.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 228,097 shares of the medical instruments supplier's stock after acquiring an additional 133,010 shares during the quarter. Cwm LLC owned approximately 0.11% of DENTSPLY SIRONA worth $3,622,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in DENTSPLY SIRONA in the first quarter worth approximately $25,000. Trust Co. of Toledo NA OH purchased a new position in DENTSPLY SIRONA in the second quarter worth approximately $27,000. Brooklyn Investment Group purchased a new position in DENTSPLY SIRONA in the first quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in DENTSPLY SIRONA in the first quarter worth approximately $26,000. Finally, Caitong International Asset Management Co. Ltd lifted its stake in DENTSPLY SIRONA by 8,003.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock worth $34,000 after acquiring an additional 2,241 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on XRAY shares. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, September 26th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, August 8th. Evercore ISI cut their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating on the stock in a report on Wednesday, October 8th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $18.00.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $12.62 on Friday. The firm's fifty day simple moving average is $13.39 and its 200-day simple moving average is $14.53. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of -2.66, a PEG ratio of 0.80 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 12 month low of $11.69 and a 12 month high of $24.86. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company's quarterly revenue was down 4.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 5.1%. The ex-dividend date of this dividend was Friday, September 26th. DENTSPLY SIRONA's payout ratio is currently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.